Spotlight

Updated: Nov 4



In this issue of GOLD, we look back at the leading news stories from the past few months in the pharmaceutical industry, covering the latest COVID-19 developments, the most prominent drug approvals, and the standout mergers and acquisitions.



29 June

Com-Cov study investigating COVID-19 vaccine combinations delivers positive results


01 July

Moderna hires Global CEO of Ogilvy, Kate Cronin, to be their first Chief Brand Officer


07 July

Biohaven disrupts migraine market with drug Nurtec as sales exceed estimates by 112%


13 July

Sanofi signs up to be a sponsor of Paris 2024 Olympic games for $94 million


21 July

AstraZeneca completes buyout of Alexion for $39 billion


26 July

BioNTech announces plans to develop a mRNA malaria vaccine


29 July

FDA approves first interchangeable biosimilar insulin product for diabetes


30 July

FDA grants Regeneron’s REGEN-COV emergency use authorisation


03 August

Sanofi buys Translate Bio for approximately $3.2 billion


05 August

Bayer acquires Vividion Therapeutics for up to $2 billion


13 August

FDA approves Jazz Pharmaceutical’s Xywav, the first treatment for idiopathic hypersomnia


16 August

FDA approves use of third dose of Moderna’s vaccine